0001628280-23-018556.txt : 20230517
0001628280-23-018556.hdr.sgml : 20230517
20230517074323
ACCESSION NUMBER: 0001628280-23-018556
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEIL GARRY ARTHUR
CENTRAL INDEX KEY: 0001586785
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37590
FILM NUMBER: 23929648
MAIL ADDRESS:
STREET 1: 555 CALIFORNIA STREET
STREET 2: SUITE 365
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avalo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001534120
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450705648
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: 410-522-8707
MAIL ADDRESS:
STREET 1: 540 GAITHER ROAD
STREET 2: SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: Cerecor Inc.
DATE OF NAME CHANGE: 20111102
4
1
wk-form4_1684323794.xml
FORM 4
X0407
4
2023-05-15
0
0001534120
Avalo Therapeutics, Inc.
AVTX
0001586785
NEIL GARRY ARTHUR
C/O AVALO THERAPEUTICS
540 GAITHER ROAD, SUITE 400
ROCKVILLE
MD
20850
1
1
0
0
CEO and Chairman of the Board
0
Stock Option (Right to Buy)
2.75
2023-05-15
4
A
0
100000
0
A
2024-05-15
2033-05-15
Common Stock
100000
100000
D
The stock option will vest in full on May 15, 2024, subject to the Reporting Person's continued service on such vesting date.
/s/ Jennifer Zoltoski, by Power of Attorney
2023-05-16